Search Results

There are 3308677 results for: content related to: The New FDA Pregnancy Labeling Requirements for Drugs

  1. Comparison Between Plasma and Urinary Oestrogen Measurements in Predicting Fetal Risk

    Australian and New Zealand Journal of Obstetrics and Gynaecology

    Volume 14, Issue 2, May 1974, Pages: 59–76, D. R. Aickin, M. A. Smith and J. B. Brown

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1479-828X.1974.tb00524.x

  2. Experienced Obstetric Nurses' Decision-Making in Fetal Risk Situations

    Journal of Obstetric, Gynecologic, & Neonatal Nursing

    Volume 29, Issue 5, September 2000, Pages: 480–490, Lois A. Haggerty and Ronald L. Nuttall

    Version of Record online : 28 JUL 2006, DOI: 10.1111/j.1552-6909.2000.tb02769.x

  3. You have free access to this content
    Recent Changes in Pregnancy and Lactation Labeling: Retirement of Risk Categories

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 4, April 2014, Pages: 389–395, Leda L. Ramoz and Nima M. Patel-Shori

    Version of Record online : 4 JAN 2014, DOI: 10.1002/phar.1385

  4. You have free access to this content
    Maternal medicine: Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 113, Issue 5, May 2006, Pages: 559–568, MK Bakker, J Jentink, F Vroom, PB Van Den Berg, HEK De Walle and LTW De Jong-Van Den Berg

    Version of Record online : 24 APR 2006, DOI: 10.1111/j.1471-0528.2006.00927.x

  5. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 1013–1018, Phoebe G. Thorpe, Suzanne M. Gilboa, Sonia Hernandez-Diaz, Jennifer Lind, Janet D. Cragan, Gerald Briggs, Sandra Kweder, Jan M. Friedman, Allen A. Mitchell, Margaret A. Honein and The National Birth Defects Prevention Study

    Version of Record online : 29 JUL 2013, DOI: 10.1002/pds.3495

  6. You have free access to this content
    Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies

    British Journal of Clinical Pharmacology

    Volume 73, Issue 2, February 2012, Pages: 248–256, Kyohei Shintaku, Satoko Hori, Hiroki Satoh, Kiyomi Tsukimori, Hitoo Nakano, Tomoyuki Fujii, Yuji Taketani, Hisakazu Ohtani and Yasufumi Sawada

    Version of Record online : 6 JAN 2012, DOI: 10.1111/j.1365-2125.2011.03921.x

  7. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 79, Issue 9, September 2007, Pages: 627–630,

    Version of Record online : 30 JUL 2007, DOI: 10.1002/bdra.20389

  8. Safety concerns regarding binge drinking in pregnancy: A review

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 94, Issue 8, August 2012, Pages: 570–575, Elizabeth Ann Conover and Kenneth Lyons Jones

    Version of Record online : 18 JUN 2012, DOI: 10.1002/bdra.23034

  9. You have free access to this content
    Abstracts

    Congenital Anomalies

    Volume 53, Issue 4, December 2013, Pages: A1–A22,

    Version of Record online : 1 DEC 2013, DOI: 10.1111/cga.12033

  10. The Patient-Centered (R)Evolution

    Birth

    Volume 34, Issue 3, September 2007, Pages: 264–266, Michael C. Klein, 1 Murray W. Enkin, 2 Andrew Kotaska and 4 Sara G. Shields 3

    Version of Record online : 17 AUG 2007, DOI: 10.1111/j.1523-536X.2007.00180.x

  11. Providing adequate directions for medication use in pregnant women and nursing mothers: An overview of pregnancy labeling

    Journal of the American Academy of Nurse Practitioners

    Volume 23, Issue 8, August 2011, Pages: 389–391, Kristine Corbett, Mary Kremzner and Toni Stifano

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1745-7599.2011.00641.x

  12. Influence of maternal, obstetric and fetal risk factors on the prevalence of birth asphyxia at term in a Swedish urban population

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 81, Issue 10, October 2002, Pages: 909–917, Ian Milsom, Lars Ladfors, Klara Thiringer, Aimon Niklasson, Anders Odeback and Eva Thornberg

    Version of Record online : 3 OCT 2002, DOI: 10.1034/j.1600-0412.2002.811003.x

  13. ASSOCIATION BETWEEN UNACCOUNTABLY HIGH MATERNAL ALPHA FETO-PROTEIN AND INCREASED FETAL RISK

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 64, Issue 3, January 1985, Pages: 275–276, F. Tom Mwambingu

    Version of Record online : 11 JAN 2011, DOI: 10.3109/00016348509155128

  14. Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: Avoiding pitfalls in the risk calculations

    American Journal of Medical Genetics

    Volume 82, Issue 4, 12 February 1999, Pages: 329–335, Susan E. Hodge, Roger V. Lebo, Anne R. Yesley, Susan M. Cheney, Heide Angle and Jeff Milunsky

    Version of Record online : 2 FEB 1999, DOI: 10.1002/(SICI)1096-8628(19990212)82:4<329::AID-AJMG10>3.0.CO;2-D

  15. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 122, Issue 8, July 2015, Pages: 1119–1129, IM Zomerdijk, R Ruiter, LMA Houweling, RMC Herings, SMJM Straus and BH Stricker

    Version of Record online : 15 OCT 2014, DOI: 10.1111/1471-0528.13128

  16. Pregnant women's view on the Swedish internet resource Drugs and Birth Defects intended for health care professionals

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 94, Issue 9, September 2015, Pages: 960–968, Ulrika Nörby, Karin Källén, Tero Shemeikka, Seher Korkmaz and Birger Winbladh

    Version of Record online : 18 JUL 2015, DOI: 10.1111/aogs.12702

  17. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs

    Nursing for Women's Health

    Volume 19, Issue 3, June/July 2015, Pages: 266–270, Heidi Collins Fantasia and Allyssa L. Harris

    Version of Record online : 8 JUN 2015, DOI: 10.1111/1751-486X.12209

  18. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 82, Issue 9, September 2008, Pages: 605–609, RADM Sandra L. Kweder

    Version of Record online : 14 AUG 2008, DOI: 10.1002/bdra.20500

  19. Increased Cut-Point of the TACER-3 Screen Reduces False Positives Without Losing Sensitivity in Predicting Risk Alcohol Drinking in Pregnancy

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 5, May 2014, Pages: 1401–1408, Lisa M. Chiodo, Virginia Delaney-Black, Robert J. Sokol, James Janisse, Yobany Pardo and John H. Hannigan

    Version of Record online : 21 MAR 2014, DOI: 10.1111/acer.12368

  20. Standardizing the Words Nurses Use to Document Elements of Perinatal Failure to Rescue

    Journal of Obstetric, Gynecologic, & Neonatal Nursing

    Volume 43, Issue 1, January/February 2014, Pages: 13–24, Catherine H. Ivory

    Version of Record online : 15 JAN 2014, DOI: 10.1111/1552-6909.12273